In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.
about
Systemic targeted alpha radiotherapy for cancer.Targeted alpha anticancer therapies: update and future prospectsPreclinical studies of targeted alpha therapy for breast cancer using 213Bi-labelled-plasminogen activator inhibitor type 2.Targeted alpha-therapy: past, present, future?Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.In vitro cytotoxicity of bismuth-213 (213Bi)-labeled-plasminogen activator inhibitor type 2 (alpha-PAI-2) on human breast cancer cells.Nerve/Glial Antigen 2: A Novel Target for Anti-Tumor Therapy in Colorectal Cancer.
P2860
Q34377594-48230A61-A24F-4ABB-9F91-1B1BFFE0D757Q34511439-F35116DA-2791-48AD-98FC-EE492A9E7A41Q36648790-C0D2223C-03AF-48EB-8F73-D1804F102491Q36691184-1FEDB5A1-6BCF-4FE3-AA68-2F58C029FD96Q37085052-7252508C-4C44-41FC-B236-686A27EC0DB3Q43907665-9000BB3D-7045-4CE5-AC93-78FFF055F2EBQ53158899-AB148C2D-2370-4459-AD2F-728345AAAAC7
P2860
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.
@en
In vitro and preclinical studies of targeted alpha therapy
@nl
type
label
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.
@en
In vitro and preclinical studies of targeted alpha therapy
@nl
prefLabel
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.
@en
In vitro and preclinical studies of targeted alpha therapy
@nl
P2093
P2860
P1433
P1476
In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer.
@en
P2093
P2860
P304
P356
10.1046/J.1463-1318.2001.00264.X
P577
2001-09-01T00:00:00Z